Big News Skyrockets Little-Known Company to Top of Tomorrow's Watchlist

View in browser Brand New Profile Coming Tonight at 8:00 PM EST or 9:30 AM EST Tomorrow Morning!   This One Has Several Potential Catalysts Requiring Your  Immediate Attention Including…   Low Float: Less Than 3M Shares Post Reverse-Split; Offering High Volatility Potential!   Market Recognition: Making an Approximate 59% Move In 1.5 Weeks,  Reaching A New July High!   Innovative Development: Leading Treatments For CNS Disorders, Immunology, and Infectious Diseases!   Clinical Success: Significant Efficacy In Phase 3 Trials For Fibromyalgia; NDA Submission In 2024!   Breakthrough Therapy: FDA Designation For Co-caine Intoxication Treatment; In Phase 2 Trials.   Announced Landmark Deal with US Government: $34M Contract From DTRA For  Broad-Spectrum Antiviral Development.   The Time to Get Ready is Now!   Take 2 Minutes Now to Connect with Us on all of Our No-Cost Platforms!   (See instructions below)   July 7, 2024   Dear reader,   Now's the time to get ready for our brand new profile.   This one just skyrocketed to the top of our radar and will need your immediate attention.   Our research is finishing a full report for you that will be delivered by 8:00 PM EST Tonight or 9:30 AM Tomorrow morning.    You see, a recent reverse-split has left this little-known biopharma with a razor-thin float of less than 3 million shares.    Adding to the excitement, a landmark $34M contract was recently awarded by the Defense Threat Reduction Agency (DTRA) to develop a broad-spectrum antiviral, emphasizing the strategic importance of this company's research in national defense.    This little-known company just surged approximately 59% in the last week and a half, crushing its 5-day moving average on its way to a new July high.   Could this be the beginning of something bigger?   Wait until you see what we discovered about this company.   Don't miss out on this one.   The time to get ready is now.   If you want to be among the first to learn the name of this company, I urge you to connect with us on all of our free platforms to receive our reports up to 10X faster than email alone.   If you haven't done so yet, please take 2 minutes to set these up right now: Confirm your mobile device is already connected to our no-cost SMS by clicking here.  Join our no-cost Telegram Channel by clicking here.  Connect with us on WhatsApp by clicking here. Do not miss out on this next profile, it's only a matter of time before Wall Street takes notice!   Please get ready now because we're announcing this next profile tonight at 8:00 PM EST or 9:30 AM EST tomorrow morning.  Sincerely,   Jeff Ackerman Managing Editor, Stock News Trends Click to connect no-cost SMS (takes less than 20 seconds) StockNewsTrends (stocknewstrends . com) is owned by TD Media LLC, a limited liability company. Disclosure: I am not a fin-an-cial adviser. All potential percentage gains are based on from the low to the high of day. StockNewsTrends full disclosure is to be read and fully understood before using StockNewsTrends website, or joining StockNewsTrends' email or text list. By viewing StockNewsTrends's website and/or reading StockNewsTrends email or text newsletter you are agreeing to StockNewsTrends's full disclosure which can be read at https://stocknewstrends.com/disclosure/ Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. StockNewsTrends (stocknewstrends . com) is owned by TD Media LLC, a limited liability company. Newsletter, 5826 New Territory Blvd. Unit #2144, Sugar Land, TX 77479, USA Unsubscribe Manage preferences